Evidence map›Paper›PMID 40206621›Full record

ArticleMayo Clinic proceedings. Digital health2023

Interdisciplinary Approach to Developing Nicotine Dependence Treatment Order Set: An Innovative Pilot Implementation.

Pravesh Sharma, Celia Kamath, Quang Anh Nguyen, Edgar Botello-Hernandez, Karen A Konzen, Rebecca J Yang, Nicole M Reinicke, Jon O Ebbert, Christi A Patten

Abstract read
In one paragraph

Article in Mayo Clinic proceedings. Digital health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pravesh SharmaBehavioral Health Research Program Psychiatry and Psychology, Mayo Clinic, Rochester, MN.
Celia KamathBehavioral Health Research Program Psychiatry and Psychology, Mayo Clinic, Rochester, MN.
Quang Anh NguyenDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN.
Edgar Botello-HernandezDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN.
Karen A KonzenDepartment of Research Systems and Support, Mayo Clinic, Jacksonville, FL.
Rebecca J YangDepartment of Research Systems and Support, Mayo Clinic, Rochester, MN.
Nicole M ReinickeDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN.
Jon O EbbertDepartment of Internal Medicine, Mayo Clinic, Rochester, MN.
Christi A PattenDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tobacco use remains the leading cause of preventable diseases and mortality in the United States. State quitline is an evidence-based tobacco cessation intervention for people who smoke. However, patients' referral to quitline has been low. To address this gap in practice, we collected stakeholder feedback and engaged in an interdisciplinary and collaborative effort to create a new nicotine dependence treatment referral system using our electronic health record-based order sets. The project was conducted in 3 phases: (1) development process, (2) dissemination and approval from practice leaders, and (3) dissemination to clinicians. With the stakeholder feedback, we updated the existing nicotine dependence order set (NDO) by including links to the state quitline and local community resources targeting the social determinants of health. We created a brief educational material on the new NDO for dissemination. We measured the intention to use, implementation outcomes, acceptance, appropriateness, and feasibility of the new NDO. In the prepresentation survey, although 81% of the participants from the leadership and 77% from the clinician groups reported using the order set in general, only 13% from the leadership and 10% from the clinician group used the existing NDO. In the postpresentation survey, nearly 100% of the leadership and clinician respondents intended to use the new NDO in their practices. Acceptance (leadership vs clinicians: 82% vs 100%), appropriateness (leadership vs clinicians: 82% vs 95%), and feasibility (leadership vs clinicians: 82% vs 100%) were high in the postpresentation survey. Despite the positive reception to the new NDO, future research is needed to test the adoption, sustainability, and effectiveness of the NDO in addressing smoking cessation outcomes.

Identifiers

PMID40206621
PMCPMC11975714

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.